CDK6 and cervical cancer: Clinical evidence also shown that the decreased expression of miR-29a in high-grade cervical cancer lesions and YY1 and CDK6 as downstream targets of miR-29a may contribute to unchecked cellular proliferation and resistance to apoptotic stimuli in HeLa cells [36,37].